Q1 Earnings Forecast for Transcat Issued By Northland Capmk

Transcat, Inc. (NASDAQ:TRNSFree Report) – Northland Capmk issued their Q1 2026 earnings estimates for shares of Transcat in a report released on Wednesday, May 21st. Northland Capmk analyst E. Jackson expects that the scientific and technical instruments company will earn $0.50 per share for the quarter. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Capmk also issued estimates for Transcat’s Q2 2026 earnings at $0.60 EPS, FY2027 earnings at $2.74 EPS, FY2028 earnings at $3.07 EPS, FY2029 earnings at $3.42 EPS and FY2030 earnings at $3.79 EPS.

A number of other brokerages have also recently issued reports on TRNS. HC Wainwright upped their price objective on shares of Transcat from $106.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday. Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a research report on Tuesday. Northland Securities reissued a “market perform” rating and issued a $85.00 price target (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Transcat currently has a consensus rating of “Hold” and a consensus target price of $114.00.

Get Our Latest Stock Analysis on Transcat

Transcat Price Performance

Shares of Transcat stock opened at $91.63 on Thursday. Transcat has a 52-week low of $67.56 and a 52-week high of $147.12. The stock has a market capitalization of $852.98 million, a price-to-earnings ratio of 49.53 and a beta of 0.69. The company has a fifty day moving average of $79.06 and a 200-day moving average of $89.79. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42.

Transcat (NASDAQ:TRNSGet Free Report) last announced its quarterly earnings data on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The business had revenue of $77.13 million during the quarter, compared to analysts’ expectations of $76.40 million. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Neuberger Berman Group LLC increased its holdings in Transcat by 1.8% during the 4th quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company’s stock valued at $92,415,000 after purchasing an additional 15,723 shares during the period. Dimensional Fund Advisors LP increased its holdings in Transcat by 5.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 209,200 shares of the scientific and technical instruments company’s stock valued at $22,121,000 after purchasing an additional 10,186 shares during the period. Rhumbline Advisers raised its holdings in Transcat by 4.1% in the 4th quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company’s stock worth $1,306,000 after purchasing an additional 486 shares in the last quarter. Barclays PLC raised its holdings in Transcat by 393.0% in the 3rd quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock worth $1,826,000 after purchasing an additional 12,061 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in Transcat by 8.5% in the 4th quarter. Principal Financial Group Inc. now owns 5,002 shares of the scientific and technical instruments company’s stock worth $529,000 after purchasing an additional 391 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Recommended Stories

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.